BIORCHESTRA, SK Biopharmaceuticals collaborate to develop miRNA-targeted therapeutics

Back to list BIORCHESTRA, SK Biopharmaceuticals collaborate to develop miRNA-targeted therapeutics BIORCHESTRA and SK Biopharmaceuticals announced today that they have forged a partnership to research and develop new therapeutic compounds…

Continue ReadingBIORCHESTRA, SK Biopharmaceuticals collaborate to develop miRNA-targeted therapeutics

BIORCHESTRA will present data on the therapeutic efficacy of their proprietary ASO against pathological miRNA, a key modulator of neuroinflammation and neurodegeneration, at the CTAD Meeting in Boston

Back to list BIORCHESTRA will present data on the therapeutic efficacy of their proprietary ASO against pathological miRNA, a key modulator of neuroinflammation and neurodegeneration, at the CTAD Meeting in…

Continue ReadingBIORCHESTRA will present data on the therapeutic efficacy of their proprietary ASO against pathological miRNA, a key modulator of neuroinflammation and neurodegeneration, at the CTAD Meeting in Boston